Our Activities

The CPMC hosts three dedicated working groups: one to address barriers to accessing biomarker and genetic testing for inherited mutations and inherited cancer risk, another to promote best practices in patient education about precision medicine, and a third to develop and encourage the use of standardized, patient-friendly terms for discussing testing.

  • Bianca Alvarez, ACCC
    Deb Collyar, PAIR
    Jessie Conta, PLUGS
    David Davenport, PMC
    Marcia Horn, ICAN
    Christie Jett, Genetic Support Foundation
    Rifeta Kajdic Hodzic, ACCC
    Brandon Leonard, LUNGevity
    Joan Levy, MRA
    Sara Lindsey Patton, IASLC
    Nikki Martin, LUNGevity
    Leah McPherson, CSC
    Jim Palma, Target Cancer Foundation
    Chad Ramsey, OCRA
    Beth Sandy, APSHO
    Lisa Schlager, FORCE
    Jilliane Sotelo, NSGC
    Shannon Stasi, PLUGS
    Pam Traxel, ACSCAN

  • Tori Best, NBTS
    Anne Mette Buhl, Clearity
    Denisse Evans, Life Raft Group
    Christie Jett, GSF
    Erica Kuhn, Komen
    Joan Levy, MRA
    Stacie Lindsey, CCF
    Nikki Martin, LUNGevity
    Tracy Moore, OCRA
    Martha Raymond, GICA
    Rachel Saks, CSC
    Jilliane Sotello, NSGC

  • Christine Calafiore, CancerCare
    Eric Konnick, CAP
    Nikki Martin, LUNGevity
    Beth Sandy, APSHO
    Claire Saxton, CSC

Presentations

Understanding Barriers in Access to Biomarker Testing and Genetic Testing for Inherited Risk/Genetic Testing for Inherited Mutations (Genetic Testing)

Cancer Precision Medicine Commons work was presented at the Patient-Centered Laboratory Utilization Services (PLUGS) Annual Meeting, June 13-14, 2024. This poster summarizes surveys conducted among healthcare providers by the Commons to better define and understand access barriers for biomarker testing and genetic testing for inherited cancer risk.